Navigation Links
WHO On Measures To Combat Spurious Medicines

At a conference held at Prague on Tuesday, the World Health Organization along with twenty technological companies discussed various means// to combat the movement of fake drugs especially in developing countries.

Howard Zucker, WHO assistant director-general for health technology, told that sale of spurious drugs in some of the poorer nations account for more than 25% of the total drug sales. He said that this issue needs the intervention of experts to chalk out a strategy that is specific for a particular nation. Some of the measures discussed in the conference included bar codes, holograms, digital water marks and radio tags.

Zucker pointed to the internet as the main reason for the spread of fake drugs business in developing and under developed countries. This problem has assumed a greater significance for health care professionals as well as drug firms as it affects their profits. Harvey Bale from International Federation of Pharmaceutical Manufacturers and Associations opined that tough governmental legislations with strict enforcement can bring in a positive change in controlling this trade.

This meeting is reported to be the first of its kind which highlighted the need to control the movement of fake drugs.
JYT
'"/>




Page: 1

Related medicine news :

1. Poor Preventive Measures Taken By Diabetics
2. Diabetics Should Adopt Better Preventive Measures
3. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
4. Bird Flu: Orissa Initiates Protective Measures
5. Germany Institutes Tough Measures To Tackle Bird Flu
6. Protection Measures against Elder Abuse
7. Pakistan Enforces Strict Bird Flu Measures, Poultry Import Banned
8. Strict Safety Measures On Import of Poultry From China
9. NHS announces further Cost cutting Measures
10. NHS Recommends Further Cost Cutting Measures
11. Safety Measures Pose an Added Expenditure for the Airlines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... Guide to ... , No matter on which side of the Atlantic devicemakers do business, ... regulations they have to follow. , In addition to the full text of the ...
(Date:6/28/2017)... ... June 28, 2017 , ... The Wharton School’s ... mid-market executives as a kick-off to the fifth annual CEO Connection Mid-Market Convention. ... the University of Pennsylvania campus, followed by the two-day convention, which will target ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/27/2017)... ... June 27, 2017 , ... DrugDev understands that ... they can trust the sponsor to pay them correctly and on time. As the ... establish payment strategies that encourage sites to work on their studies. , At a ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
Breaking Medicine News(10 mins):
(Date:6/9/2017)... AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), ... sale and distribution of the AeroForm® Tissue Expander System, ... commercial roll-out in the United States ... hundred (100) medical institutions and health systems, located throughout ... alternative for women who choose reconstructive surgery following a ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: